Literature DB >> 19679599

Myeloid RelA regulates pulmonary host defense networks.

C Hess1, C Herr, C Beisswenger, T Zakharkina, R M Schmid, R Bals.   

Abstract

The pulmonary innate immune system in the respiratory tract eliminates inhaled pathogens. Several cell types contribute to host defense within a complex network. The aim of this study was to evaluate the role of macrophages during pneumonia and in the regulation of the epithelial response to microorganisms. We performed lung infection models in mice lacking myeloid RelA/p65. To study the mechanistic relationships between individual cell types, we applied co-culture models composed of airway epithelial cells (AECs) and macrophages. Mice lacking myeloid RelA/p65 showed significantly decreased bacterial clearance, cytokine expression and neutrophil influx. In addition, the induction of epithelial keratinocyte chemoattractant expression was blunted in these animals. In vitro, AECs were largely insensitive to ligands of Toll-like receptor (TLR)2 or TLR5. Exposure to secretory products of macrophages results in an increased release of pro-inflammatory cytokines and augmented antimicrobial activity. This was associated with increased expression of TLR genes and surface expression of the proteins. Experiments with blocking antibodies showed that the effect of macrophages depends on secreted mediators, including tumour necrosis factor-alpha. In conclusion, the present data show that myeloid RelA is critical for pulmonary host defense. One important mechanism is that macrophages induce the sensitivity of AEC's to microbial patterns.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19679599     DOI: 10.1183/09031936.00196408

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  12 in total

1.  Suppression of epithelial signal transducer and activator of transcription 1 activation by extracts of Aspergillus fumigatus.

Authors:  Bharat Bhushan; Tetsuya Homma; James E Norton; Quan Sha; Jason Siebert; Dave S Gupta; James W Schroeder; Robert P Schleimer
Journal:  Am J Respir Cell Mol Biol       Date:  2015-07       Impact factor: 6.914

2.  A deficiency in cathelicidin reduces lung tumor growth in NNK/NTHi-induced A/J mice.

Authors:  Yiwen Yao; Junlu Wu; Hao Zhou; Jenni Firrman; Weidong Xiao; Zujun Sun; Dong Li
Journal:  Am J Cancer Res       Date:  2018-07-01       Impact factor: 6.166

3.  IL-17C mediates the recruitment of tumor-associated neutrophils and lung tumor growth.

Authors:  C Jungnickel; L H Schmidt; L Bittigkoffer; L Wolf; A Wolf; F Ritzmann; A Kamyschnikow; C Herr; M D Menger; T Spieker; R Wiewrodt; R Bals; C Beisswenger
Journal:  Oncogene       Date:  2017-03-27       Impact factor: 9.867

Review 4.  Dynamics of lung defense in pneumonia: resistance, resilience, and remodeling.

Authors:  Lee J Quinton; Joseph P Mizgerd
Journal:  Annu Rev Physiol       Date:  2014-08-13       Impact factor: 19.318

Review 5.  The innate immune function of airway epithelial cells in inflammatory lung disease.

Authors:  Pieter S Hiemstra; Paul B McCray; Robert Bals
Journal:  Eur Respir J       Date:  2015-02-19       Impact factor: 16.671

6.  Earliest innate immune responses require macrophage RelA during pneumococcal pneumonia.

Authors:  Lynnelle A Pittet; Lee J Quinton; Kazuko Yamamoto; Bryanne E Robson; J Daniel Ferrari; Hana Algül; Roland M Schmid; Joseph P Mizgerd
Journal:  Am J Respir Cell Mol Biol       Date:  2011-01-07       Impact factor: 6.914

Review 7.  Integrative Physiology of Pneumonia.

Authors:  Lee J Quinton; Allan J Walkey; Joseph P Mizgerd
Journal:  Physiol Rev       Date:  2018-07-01       Impact factor: 37.312

Review 8.  Potential of helper-dependent Adenoviral vectors in CRISPR-cas9-mediated lung gene therapy.

Authors:  Ranmal Avinash Bandara; Ziyan Rachel Chen; Jim Hu
Journal:  Cell Biosci       Date:  2021-07-23       Impact factor: 7.133

9.  Tumor-produced versican V1 enhances hCAP18/LL-37 expression in macrophages through activation of TLR2 and vitamin D3 signaling to promote ovarian cancer progression in vitro.

Authors:  Dong Li; Xuan Wang; Jun-Lu Wu; Wen-Qiang Quan; Li Ma; Fan Yang; Kai-Yin Wu; Hai-Ying Wan
Journal:  PLoS One       Date:  2013-02-12       Impact factor: 3.240

10.  CDA-2, a urinary preparation, inhibits lung cancer development through the suppression of NF-kappaB activation in myeloid cell.

Authors:  Xuan Wang; Cui-Min Jiang; Hai-Ying Wan; Jun-Lu Wu; Wen-Qiang Quan; Robert Bals; Kai-Yin Wu; Dong Li
Journal:  PLoS One       Date:  2012-12-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.